Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal FOXP3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Rabbit polyclonal FOXP3 antibody was raised against a 15 amino acid peptide near the carboxy terminus of human FOXP3. The immunogen is located within the last 50 amino acids of FOXP3. |
Rabbit anti-STAT1 (Phospho-Tyr701) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT1 around the phosphorylation site of tyrosine 701 (T-G-YP-I-K). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-HIF1a Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 780 aa to the C-terminus of human HIF1a produced in E. coli. |
Rabbit anti-NF-kB p105/p50 (Phospho-Ser337) polyclonal antibody (Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanNF-κB p105/p50 around the phosphorylation site of serine 337 (R-K-SP-D-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Smad2/3 (Thr8) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Smad2/3 around the phosphorylation site of Threonine 8 |
| Modifications | Phospho-specific |
Rabbit Polyclonal antibody to LDB1 (LIM domain binding 1)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 86 and 411 of LDB1 (Uniprot ID#Q86U70) |
Rabbit Polyclonal PPARGC1A Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PPARGC1A antibody was raised against a 19 amino acid peptide near the carboxy terminus of human PPARGC1A. The immunogen is located within the last 50 amino acids of PPARGC1A. |
Rabbit polyclonal anti-PGC-1alpha antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide surrounding amino acid 766 of mouse PGC-1alpha |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal antibody to Rad54 (alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae))
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 2161 and 2443 of Rad54 (Uniprot ID#P46100) |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Nuclear Receptor NR4A1 (Ab-351) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Nuclear Receptor NR4A1 around the phosphorylation site of serine 351 (L-P-SP-K-P). |
Rabbit anti-PARP1 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide of human PARP1 |
Rabbit anti-TFAM Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human TFAM |
WT1 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human WT1 |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal MITF (Ab-180/73) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human MITF around the phosphorylation site of serine 180/73 (P-N-SP-P-M). |
Rabbit polyclonal LMO4 Antibody (Center)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This LMO4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 104-131 amino acids from the Central region of human LMO4. |
Rabbit Polyclonal CrkII (Tyr221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CrkII around the phosphorylation site of Tyrosine 221 |
| Modifications | Phospho-specific |
Rabbit Polyclonal IRF7 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | IRF7 antibody was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human IRF7. The immunogen is located within amino acids 420 - 470 of IRF7. |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-HEY2 antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human HEY2. |
Rabbit polyclonal PCGF6 Antibody (Center)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PCGF6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 190-217 amino acids from the Central region of human PCGF6. |
Mouse Monoclonal anti-NFATc1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Goat Polyclonal Anti-HIF1a Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 470 to 590 aa of human HIF1a produced in E. coli. |
Goat Anti-EBF1 / COE1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HNQLPALANTSV, from the internal region of the protein sequence according to NP_076870.1. |
USD 345.00
In Stock
Rabbit polyclonal anti-KAP0 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from N-terminal of human KAP0. |
Rabbit polyclonal anti-HOXC6 antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from C-terminal of human HOXC6. |
Rabbit polyclonal HEYL Antibody (N-term)
| Applications | IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HEYL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 26-54 amino acids from the N-terminal region of human HEYL. |
Rabbit Polyclonal STAT5A (Ser780) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A around the phosphorylation site of Serine 780 |
| Modifications | Phospho-specific |
Rabbit Polyclonal STAT5A/B (Ser725/730) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human STAT5A/B around the phosphorylation site of Serine 725/730 |
| Modifications | Phospho-specific |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Conjugates
- Unconjugated
Families
- Transcription Factors
Citations
- Yes
Filter by
Target Symbol
- CTNNB1 (5)
- SOX17 (5)
- ZEB1 (5)
- ARNTL (4)
- CDX2 (4)
- GATA4 (4)
- KEAP1 (4)
- NR4A3 (4)
- PRRX1 (4)
- SNAI2 (4)
- SQSTM1 (4)
- HIF1A (3)
- PARP1 (3)
- PPARGC1A (3)
- PRKAR1A (3)
- RELA (3)
- STAT3 (3)
- TP63 (3)
- ZEB2 (3)
- ARNT (2)
- CRABP2 (2)
- EGR2 (2)
- EPAS1 (2)
- ESR1 (2)
- ETS2 (2)
- EZH2 (2)
- FOSL1 (2)
- FOXP3 (2)
- GSC (2)
- HOXD10 (2)
- NFKB1 (2)
- PAX5 (2)
- PDX1 (2)
- POU5F1 (2)
- SATB1 (2)
- SEC14L2 (2)
- SIRT6 (2)
- SMURF2 (2)
- SSB (2)
- STAT5A (2)
- TGFB1 (2)
- TLE1 (2)
- TP53 (2)
- TWIST2 (2)
- WWTR1 (2)
- ATRX (1)
- CCNE1 (1)
- CRK (1)
- CUX1 (1)
- EBF1 (1)
- FOXC1 (1)
- FOXO1 (1)
- FOXP1 (1)
- GAS7 (1)
- GATA3 (1)
- HDAC9 (1)
- HEY2 (1)
- HEYL (1)
- HHEX (1)
- HNF4A (1)
- HOXC6 (1)
- HOXC8 (1)
- IRF3 (1)
- IRF7 (1)
- LDB1 (1)
- LMO4 (1)
- MDM2 (1)
- MITF (1)
- MYC (1)
- MYCN (1)
- MYOD1 (1)
- NEUROD1 (1)
- NFATC1 (1)
- NFATC2 (1)
- NONO (1)
- NR3C1 (1)
- NR4A1 (1)
- PCGF6 (1)
- POFUT1 (1)
- POLR2C (1)
- RNF2 (1)
- RUNX2 (1)
- RUNX3 (1)
- SMAD3 (1)
- SMAD7 (1)
- SMARCA4 (1)
- SOD2 (1)
- SOX2 (1)
- SOX9 (1)
- SPDEF (1)
- STAT1 (1)
- TFAM (1)
- VAMP7 (1)
- VHL (1)
- WT1 (1)
Applications
Antibody Hosts
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (35)
- Wnt signaling pathway (18)
- Chronic myeloid leukemia (15)
- Prostate cancer (15)
- Pancreatic cancer (14)
- MAPK signaling pathway (13)
- Acute myeloid leukemia (11)
- Adipocytokine signaling pathway (11)
- Colorectal cancer (11)
- Renal cell carcinoma (11)
- Adherens junction (10)
- Apoptosis (10)
- Chemokine signaling pathway (10)
- Small cell lung cancer (9)
- Cell cycle (8)
- Endometrial cancer (8)
- Huntington's disease (8)
- Insulin signaling pathway (8)
- Neurotrophin signaling pathway (8)
- Thyroid cancer (8)
- Toll-like receptor signaling pathway (8)
- Ubiquitin mediated proteolysis (8)
- B cell receptor signaling pathway (7)
- Basal cell carcinoma (7)
- Cytosolic DNA-sensing pathway (7)
- Jak-STAT signaling pathway (7)
- RIG-I-like receptor signaling pathway (7)
- T cell receptor signaling pathway (7)
- TGF-beta signaling pathway (7)
- Focal adhesion (6)
- Melanogenesis (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Epithelial cell signaling in Helicobacter pylori infection (5)
- Leukocyte transendothelial migration (5)
- Maturity onset diabetes of the young (5)
- NOD-like receptor signaling pathway (5)
- Pathogenic Escherichia coli infection (5)
- Tight junction (5)
- Bladder cancer (4)
- Circadian rhythm - mammal (4)
- ErbB signaling pathway (4)
- Melanoma (4)
- p53 signaling pathway (4)
- Base excision repair (3)
- Endocytosis (3)
- Glioma (3)
- Metabolic pathways (3)
- mTOR signaling pathway (3)
- Allograft rejection (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Antigen processing and presentation (2)
- Autoimmune thyroid disease (2)
- Axon guidance (2)
- Cell adhesion molecules (CAMs) (2)
- Cytokine-cytokine receptor interaction (2)
- Dilated cardiomyopathy (2)
- Dorso-ventral axis formation (2)
- Graft-versus-host disease (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Natural killer cell mediated cytotoxicity (2)
- Non-small cell lung cancer (2)
- Systemic lupus erythematosus (2)
- Type I diabetes mellitus (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Viral myocarditis (2)
- Fc gamma R-mediated phagocytosis (1)
- Neuroactive ligand-receptor interaction (1)
- Oocyte meiosis (1)
- Purine metabolism (1)
- Pyrimidine metabolism (1)
- RNA polymerase (1)
- Regulation of actin cytoskeleton (1)
- SNARE interactions in vesicular transport (1)